Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Fall 2018 - Integrated Care
Download Issue
Share
Up Front
Publisher's Corner
Exciting Advancements in Disease Diagnosis and Treatment
By Patrick M. Schmidt
Features
Medical Marijuana and the Opioid Crisis
By
Diane L.M. Cook
The Future of Cord Blood
By
Ronale Tucker Rhodes, MS
Myths and Facts: Complex Regional Pain Syndrome
By
Ronale Tucker Rhodes, MS
Artificial Intelligence and Big Data
By
Amy Scanlin, MS
Biosimilars: From Concept to Reality
By
Trudie Mitschang
BioTrends Watch
Washington Report
CMS Launches New Voluntary Bundled Payment Model
CMS Proposes Paying for Telehealth and Overhauling Medicare Billing
FDA Introduces Biosimilar Action Plan
HHS Loosens Restrictions on Short-Term Health Plans
CMS Restores Risk Adjustment Program
Reimbursement FAQs
Proposed 2019 OPPS Rules
Industry News
Study Finds Vaccines Don't Weaken Babies' Immune Systems
Study Finds Mumps Vaccine Protection Wanes Over Time
Study Finds Asthma Treatments for Kids More Likely to Fail Without Flu Shot
CDC OKs FluMist for 2018-19 Influenza Season
Cell-Based and Recombinant Vaccines More Effective in 2017-18 Flu Season
Heart Failure Death Risk Drops 50% in Those Who Receive Flu Vaccine
FDA Chooses Influenza Vaccine Strains for the 2018-19 Season
Flu Vaccine Recommendations Updated by CDC and AAP
Tuberculosis Vaccine May Reverse Type 1 Diabetes
WHO Recommends Typhoid Vaccine in Children in Endemic Countries
Immune System Response Discovery in Newborns Could Lead to Earlier Vaccine Administration
Current Pertussis Vaccine Mounts a Weaker Recall Response with Booster Shots
FDA Approves First Treatment for High-Risk Prostate Cancer
CDC Expects Shortage of New Shingles Vaccines
Zika Virus Blood Screening Guidelines Revised by FDA
Updated C. Diff Guidelines Reflect New Treatment Options and Recommendations
BioFocus
Industry Insight
Subcutaneous Immune Globulin Maintenance Therapy for CIDP: An Idea Whose Time Has Come
By Keith Berman, MPH, MBA
Patient Profile
Medical Marijuana: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Medical Marijuana: A Physician's Perspective
By Trudie Mitschang
Disease Profile
Update on Migraines
By Jim Trageser
BioSources
BioResearch
Frequency-Escalated Prophylaxis for Severe Hemophilia A Reduces Clotting Factor Usage with Minimal Long-Term Arthropathy
Chronic Human Albumin Therapy Prolongs Survival in Patients with Decompensated Cirrhosis